Anti-Cancer Stem-Cell-Targeted Therapies in Prostate Cancer

Anti-Cancer Stem-Cell-Targeted Therapies in Prostate Cancer

Prostate cancer (PCa) is the second-most commonly diagnosed cancer in men around the world. It is treated using a risk stratification approach in accordance with the National Comprehensive Cancer Network (NCCN) in the United States. The main treatment options for early PCa include external beam radi...

Full description

Bibliographic Details
Main Authors: Samantha Gogola, Michael Rejzer, Hisham F. Bahmad, Ferial Alloush, Yumna Omarzai, Robert Poppiti
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
prostate cancer
therapy resistance
cancer stem cells
targeted therapy
Online Access:https://www.mdpi.com/2072-6694/15/5/1621

Similar Items

Similar Items